Background Aortic-valve stenosis can be complicated by bleeding that is associated with
acquired type 2A von Willebrand syndrome. However, the prevalence and cause of the …

Abstract Aims The MITRA‐FR trial showed that among symptomatic patients with severe
secondary mitral regurgitation, percutaneous repair did not reduce the risk of death or …

Background—Significant postprocedural aortic regurgitation (AR) is observed in 10% to
20% of cases after transcatheter aortic valve replacement (TAVR). The prognostic value and …

Background Postprocedural aortic regurgitation occurs in 10 to 20% of patients undergoing
transcatheter aortic-valve replacement (TAVR) for aortic stenosis. We hypothesized that …

Objective To evaluate the predictors of pulmonary artery systolic pressure (PASP) in organic
mitral regurgitation (MR) and its prognostic value after surgery. Design Prospective …

Background Recent studies have demonstrated that aldosterone levels measured in
patients with heart failure or acute myocardial infarction (MI) are associated with long-term …

Background—To assess the prevalence, determinants, and prognosis value of right
ventricular (RV) ejection fraction (EF) impairment in organic mitral regurgitation. Methods …

Rationale: Percutaneous aortic valve procedures are a major breakthrough in the
management of patients with aortic stenosis. Residual gradient and residual aortic …

OBJECTIVE: The Ross procedure is widely used for aortic valve disease in patients who are
still growing and young adults with active lifestyles or the desire for pregnancy. The need for …

OBJECTIVE: Bone marrow stem cells, especially the mesenchymal stem cell subpopulation,
have been used to create in vitro tissue-engineered heart valves. We hypothesized that …